Skip to main content
SpringerLink
Log in

Antimikrobielle Therapie bei ausgewählten Infektionen

  • Chapter
Check-up Anästhesiologie

  • 1688 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 34.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • American Thoracic Society (1996) Hospital-acquired pneumonia in adults: Diagnosis, assessment for severity, initial antimicrobial therapy and preventive strategies. Am J Respir Crit Care Med 153: 1711–1725

    Google Scholar 

  • Bartlett JG, Dowell SF, Mandell LA et al. (2000) Practice guidelines for the management of community acquired pneumonia in adults. Clin Infect Dis 31: 347–382

    Article  PubMed  Google Scholar 

  • Böhme A, Ruhnke M et al. (2003) Treatment of fungal infections in hematology and oncology — guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82Suppl 2: 133–140. Epub 2003 Sep 09

    Article  Google Scholar 

  • Guidelines for the management of adults with community acquired pneumonia (2001) Diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J Respir Crit Care Med 163:1730–1754

    Google Scholar 

  • Horstkotte D, Follath F, Gutschik E, Lengyel M, Oto A et al. (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European society of cardiology. Eur Heart J 25: 267–276

    Article  PubMed  Google Scholar 

  • Ioanas M, Ferrer R, Angrill J et al. (2001) Microbial investigation in ventilator-associated pneumonia. Eur Respir J 17(4): 791–801 (Review)

    Article  PubMed  Google Scholar 

  • Lode H, Schaberg T, Raffenberg M (1997) Therapie der nosokomialen Pneumonie. Dtsch Med Wochenschr 122: 93–96

    PubMed  Google Scholar 

  • Lorenz J, Bodmann KF, Bauer TT et al. (2003) German Society for Anesthesiology and Intensive Care (DGAI). Nosocomial pneumonia: prevention, diagnosis, treatment. Pneumologie 57: 532–545

    Article  PubMed  Google Scholar 

  • Mandell LA, Bartlett JG, Dowell SF, File TM, Musher DM et al. (2003) Infectious Diseases Society of America. Updates of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37: 1405–3143

    Article  PubMed  Google Scholar 

  • Maschmeyer G, Böhme A, Buchheidt D et al. (2004) Diagnostik und Therapie von Infektionen bei Patienten in der Hämatologie und Onkologie. Leitlinien der Sektion Infektionen in der Hämatologie/ Onkologie der Paul-Ehrlich-Gesellschaft e. V. Chemother J 13: 134–141

    Article  Google Scholar 

  • Mayer J, Campbell GD Jr (1996) ATS recommendations for treatment of adults with hospital-acquired pneumonia. Infect Med 13: 1027–1029, 1033–1036, 1044

    Google Scholar 

  • Memel LA et al. (2000) Ann Intern Med 132: 391–402

    PubMed  Google Scholar 

  • Pappas PG, Rex JH, Sobel JD, Filler SG et al. (2004) Guidelines for Treatment of Candidiasis. Clin Infect Dis 38: 161–189

    Article  PubMed  Google Scholar 

  • Paul M, Benuri-Silbiger I, Soares-Weiser K, Leibovici L (2004) Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis for randomised trials. BMJ 328: 668–682

    Article  PubMed  Google Scholar 

  • Paul-Ehrlich-Gesellschaft für Chemotherapie e. V. (1994) Konsensuskonferenz: Cephalosporine zur parenteralen Applikation. Chemother J 3: 101–115

    Google Scholar 

  • Vogel F et al. (1999) PEG-Empfehlungen. Parenterale Antibiotikatherapie bei Erwachsenen. Chemother J 1: 2–45

    Google Scholar 

  • Vogel F et al. (2000) Rationale Therapie bakterieller Atemwegsinfektionen. Chemother J 9: 3–23

    Google Scholar 

  • Vogel F, Bodmann K-F, und die Expertenkommission der Paul-Ehrlich-Gesellschaft (2004) Empfehlungen zur kalkulierten parenteralen Initialtherapie bakterieller Erkrankungen bei Erwachsenen. Chemotherapie Journal (in press)

    Google Scholar 

  • Vogel F, Stille W, Tauchnitz C, Stolpmann R (1996) Positionspapier zur Antibiotikatherapie in der Klinik. Chemother J 5: 23–27

    Google Scholar 

  • Haimi-Cohen Y, Husain N, Meenan J et al. (2001) Vancomycin and ceftazidime bioactivities persist for at least 2 weeks in the lumen in ports: simplifying treatment of port-associated bloodstream infections by using the antibiotic lock technique. Antimicrob Agents. Chemother 45(5): 466, 1565–1567

    Article  Google Scholar 

  • de Gans J, van de Beek D, European Dexamethasone in Adulthood Bacterial Meningitis Study Investigators (2002) Dexamethasone in adults with bacterial meningitis. N Engl J Med 14,347: 1549–1556

    Article  Google Scholar 

  • Molyneux EM, Walsh AL, Forsyth H, Tembo M, Mwenechanya JKK, Bwanaisa L, Njobvu A, Rogerson S, Malenga G (2002) Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 20,360 (9328): 211–218

    Article  Google Scholar 

  • Ally R, Schurmann D, Kreisel W et al. (2001) A randomized doubleblind double-dummy multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients. Clin Infect Dis 33,9: 1447–1454

    Article  PubMed  Google Scholar 

  • Bohme A, Ruhnke M, Buchheidt D et al. (2003) Treatment of fungal infections in hematology and oncology — guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol 82Suppl 2:133–140

    Article  Google Scholar 

  • Denning DW (2003) Echinocandin antifungal drugs. Lancet 362(390): 1142–1151

    Article  PubMed  Google Scholar 

  • Denning DW, Ribaud P, Milpied N et al. (2002) Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis 34,5: 563–571

    Article  PubMed  Google Scholar 

  • Donnelly JP, De Pauw BE (2004) Voriconazole — a new therapeutic agent with an extended spectrum of antifungal activity. Clin Microbiol Infect 10Suppl 1: 107–117

    Article  PubMed  Google Scholar 

  • Herbrecht R, Denning DW, Patterson et al. (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347,6: 408–415

    Article  PubMed  Google Scholar 

  • Kartsonis NA, Saah A, Lipka CJ et al. (2004) Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study. J Antimicrob Chemother 53,5: 878–881

    Article  PubMed  Google Scholar 

  • Maertens J, Raad I, Petrikkos G et al. (2002) Update of the multicenter noncomparative study of caspofungin (CAS) in adults with invasive aspergillosis (IA) refractory (R) or intolerant (I) to other antifungal agents: analysis of 90 Abstracts of the 41 Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego Sep 27, 30: 3269

    Google Scholar 

  • Mora-Duarte J, Betts R, Rotstein C et al. (2002) Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 347,25: 2020–2029

    Article  PubMed  Google Scholar 

  • Pappas PG, Rex JH, Sobel JD et al. (2004) Guidelines for treatment of candidiasis. Clin Infect Dis 38,2: 161–189

    Article  PubMed  Google Scholar 

  • Rex JH, Bennett JE, Sugar AM et al. (1994) A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med 331,20: 1325–1330

    Article  PubMed  Google Scholar 

  • Bernhard GR et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344: 699–709

    Article  PubMed  Google Scholar 

Download references

Editor information

Editors and Affiliations

  1. Ärztlicher Direktor und Vorstandsvorsitzender, Universitätsklinikum Münster, Domagkstr. 5, 48149, Münster

    Wolfgang J. Kox

  2. Klinik für Anästhesiologie und operative Intensivmedizin, Campus Charité Mitte, Charité Universitätsmedizin — Berlin, Schumannstr. 20-21, 10098, Berlin

    Claudia D. Spies (Kommissarische Klinikdirektorin) (Kommissarische Klinikdirektorin)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

(2005). Antimikrobielle Therapie bei ausgewählten Infektionen. In: Kox, W.J., Spies, C.D. (eds) Check-up Anästhesiologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27219-4_25

Download citation

  • DOI: https://doi.org/10.1007/3-540-27219-4_25

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-23093-9

  • Online ISBN: 978-3-540-27219-9

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation